Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity

All-trans-retinoic acid is a potent inhibitor of cell proliferation and inducer of differentiation. However, the clinical use of all-trans-retinoic acid in the treatment of cancer is significantly hampered by its toxicity and the prompt emergence of resistance, believed to be caused by increased all...

Descripción completa

Detalles Bibliográficos
Autores principales: Van heusden, J, Van Ginckel, R, Bruwiere, H, Moelans, P, Janssen, B, Floren, W, van der Leede, B J, van Dun, J, Sanz, G, Venet, M, Dillen, L, Van Hove, C, Willemsens, G, Janicot, M, Wouters, W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375285/
https://www.ncbi.nlm.nih.gov/pubmed/11870544
http://dx.doi.org/10.1038/sj.bjc.6600056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375285/
https://www.ncbi.nlm.nih.gov/pubmed/11870544
http://dx.doi.org/10.1038/sj.bjc.6600056

Ejemplares similares